Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Varma

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
The American Journal of Cardiology|May 11, 2010
Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study)Antonio Abbate, Michael C Kontos, John D Grizzard, et al.
New Microbes and New Infections|October 21, 2024
The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication eraParminder Singh, Sathvik Belagodu Sridhar, Javedh Shareef, et al.
The American Journal of Cardiology|March 5, 2013
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]Antonio Abbate, Benjamin Wallace Van Tassell, Giuseppe Biondi-Zoccai, et al.
Journal of Clinical Lipidology|December 28, 2022
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
The American Journal of Cardiology|May 11, 2010
Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study)Antonio Abbate, Michael C Kontos, John D Grizzard, et al.
New Microbes and New Infections|October 21, 2024
The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication eraParminder Singh, Sathvik Belagodu Sridhar, Javedh Shareef, et al.
The American Journal of Cardiology|March 5, 2013
Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]Antonio Abbate, Benjamin Wallace Van Tassell, Giuseppe Biondi-Zoccai, et al.
Journal of Clinical Lipidology|December 28, 2022
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of IndiaRaman Puri, Vimal Mehta, P Barton Duell, et al.
Pageof 7